Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized Epilepsy

作者：Emanuele Cerulli Irelli, E. Cocchi, Joanna Gesche, J. Peña-Ceballos, Roberto H. Caraballo, Simona Lattanzi, Gionata Strigaro, A. Morano, Patrick B. Moloney, E. Ferlazzo, A. Pascarella, Adolfo Mazzeo, A. D’Aniello, C. Pizzanelli, C. Milano, L. Giuliano, Veronica Viola, B. Mostacci, F. Fortunato, Patrizia Pulitano, Margherita Burani, S. Meletti, Pietro Pignatta, Marco Perulli, D. Battaglia, Eleonora Rosati, N. Delanty, G. Di Gennaro, A. Gambardella, A. Labate, F. Operto, A. Giallonardo, C. P. Beier, C. di Bonaventura · 发表于：JAMA Network Open · 年份：2025 · DOI：10.1001/jamanetworkopen.2025.0354 · 被引用次数：7 · 研究领域：Medicine

This comparative effectiveness study evaluates effectiveness and safety of substitution monotherapy vs add-on therapy as second-line options for women who might become pregnant with idiopathic generalized epilepsy after failure of first-line antiseizure medications other than valproic acid.